Cagrilintide
Cagrilintide is a pharmaceutical drug with 28 clinical trials. Currently 9 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
2
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
17 of 17 finished
0.0%
0 ended early
9
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Clinical Trials (28)
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28